Deprecated: Required parameter $field follows optional parameter $value in /customers/6/e/3/senatormedical.se/httpd.www/wp-content/plugins/stm-gdpr-compliance/includes/plugins/GravityForms.php on line 142 Warning: Cannot modify header information - headers already sent by (output started at /customers/6/e/3/senatormedical.se/httpd.www/wp-content/plugins/stm-gdpr-compliance/includes/plugins/GravityForms.php:142) in /customers/6/e/3/senatormedical.se/httpd.www/wp-includes/feed-rss2.php on line 8 chemo hair loss – Senator Medical AB https://www.senatormedical.se Strategic partner in Healthcare business Tue, 27 Aug 2019 09:26:53 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://www.senatormedical.se/wp-content/uploads/2018/11/cropped-Senator-Logo.jpg chemo hair loss – Senator Medical AB https://www.senatormedical.se 32 32 60550935 WHAT IS SCALP COOLING? https://www.senatormedical.se/what-is-scalp-cooling/ https://www.senatormedical.se/what-is-scalp-cooling/#respond Tue, 27 Aug 2019 09:26:42 +0000 https://www.senatormedical.se/?p=1943 Oncology sponsored Article

Scalp cooling is a new approach to reduce chemotherapy-induced alopecia that has been used by patients worldwide for decades. Reduced temperature results in a reduced blood flow to the scalp area so that less chemotherapy reaches the hair cells. Therefore, hair cells are not exposed to the full dose of chemotherapy and may be able to survive the chemotherapy treatment. As a result, it is less likely to fall out.

No alt text provided for this image
How Scalp Cooling Works

Two physiologic reactions occur during scalp cooling:

1. Reduced blood flow

Vasoconstriction in the scalp area limits the amount of chemotherapy delivered to the hair follicles.

2. Reduced metabolism

Lower scalp temperature decreases the reaction rate of normal cellular activity in the localized scalp area to slow dramatically.

With these two reactions, the follicles are significantly reduced.

Why Scalp Cooling Matters

A patient’s hair can be a part of their identity, and one of the most devastating side effects of chemotherapy. Chemotherapy-induced alopecia is an unwelcome reminder of disease, one that can negatively affect self-image, confidence, overall sense of well-being and a patient’s attitude toward treatment.

Hair loss is no longer inevitable. The DigniCap Scalp Cooling System is an approach to reduce chemotherapy-induced alopecia, used successfully by patients worldwide to maintain their privacy, self-esteem and control during a critical period of treatment.

References: Dignicap

 
]]>
https://www.senatormedical.se/what-is-scalp-cooling/feed/ 0 1943
Importance of Body image for women (Breast Cancer Article) https://www.senatormedical.se/importance-of-body-image-for-women-breast-cancer-article-dignicap-senator-medical-ab/ https://www.senatormedical.se/importance-of-body-image-for-women-breast-cancer-article-dignicap-senator-medical-ab/#respond Mon, 19 Aug 2019 12:23:05 +0000 https://www.senatormedical.se/?p=1923 Body image in women with breast cancer using a scalp cooling system to reduce chemotherapy induced hair-loss

Background: Most women consider hair to be an important part of body image. Alopecia is an emotionally traumatic side effect for breast cancer patients undergoing adjuvant chemotherapy. The DigniCap™ Scalp Cooling System is the first scalp cooling system cleared by the US Food and Drug Administration to reduce the likelihood of chemotherapy induced alopecia.

Methods: Quality of Life (QOL) data were collected as part of a prospective clinical trial evaluating the clinical performance of scalp cooling in women with early stage BC receiving adjuvant chemotherapy.

The study’s primary endpoint was hair loss as evaluated by patient self-assessment. Treatment success was defined as ≤ 50% hair loss. QOL was evaluated by the EORTC-QLQ-BR23 (BR23) administered at baseline, last chemotherapy cycle, and one month later. For BR23, 4 response categories were collapsed to 2 categories (Not at all/A little bit and Quite a bit/Very much) for analysis. QOL was compared between those with success vs. failure of scalp cooling.

Results: 101 patients were evaluable for the primary endpoint: Success was seen in 67 (66.3%) pts. QOL at study entry was comparable between pts with scalp cooling success or failure for each item in the BR23 questionnaire. Results reported as percentages of patients in each group who answered either quite a bit or very much to body image-related questions on the BR23 questionnaire are displayed in Table 1.

Reference: Cancer Research Journal

]]>
https://www.senatormedical.se/importance-of-body-image-for-women-breast-cancer-article-dignicap-senator-medical-ab/feed/ 0 1923